Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 1. Construction of the basic framework.
Journal of medicinal chemistry·1998
Effects of a nonpeptide bradykinin B2 receptor antagonist, FR167344, on different in vivo animal models of inflammation.
British journal of pharmacology·1998
Comparative outcomes of advanced medical rescue therapies in steroid-refractory acute severe ulcerative colitis: a systematic review and network meta-analysis.
Frontiers in gastroenterology (Lausanne, Switzerland)·2026
Early multimodal vasopressor strategy in septic shock: results of the TRICYCLE randomized controlled trial.
Critical care (London, England)·2026
Long-term outcomes of prophylactic cardioprotection in early-stage breast cancer patients on non-anthracycline anti-HER2 therapy.
Cardio-oncology (London, England)·2026
Continuous infusion of granulocyte colony-stimulating factor is associated with an advantage in neutrophil recovery in pediatric oncologic disorders.
Cancer chemotherapy and pharmacology·2026
Ciprofloxacin beyond antibacterial therapy: pharmacological mechanisms, anticancer activity, and translational limitations.
Naunyn-Schmiedeberg's archives of pharmacology·2026